KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). (Q45117346)

9 December 2017

title

KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). (English)

1 reference

9 December 2017

9

1 reference

9 December 2017

R L Levine

1

1 reference

9 December 2017

M Wadleigh

2

1 reference

9 December 2017

D W Sternberg

3

1 reference

9 December 2017

I Wlodarska

4

1 reference

9 December 2017

I Galinsky

5

1 reference

9 December 2017

R M Stone

6

1 reference

9 December 2017

D J DeAngelo

7

1 reference

9 December 2017

D Gary Gilliland

8

1 reference

9 December 2017

publication date

1 January 2005

1 reference

9 December 2017

1 reference

9 December 2017

volume

19

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

27-30

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403548

9 December 2017

exact match

0 references

cites work

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Identification and characterization of a novel Dvl-binding protein that suppresses Wnt signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Mutations in the Drosophila hook gene inhibit endocytosis of the boss transmembrane ligand into multivesicular bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Unbiased whole-genome amplification directly from clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

Successful use of the same slide for consecutive fluorescence in situ hybridization experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

inferred from DOI database lookup

7 January 2021

based on heuristic

HUGE: a database for human KIAA proteins, a 2004 update integrating HUGEppi and ROUGE.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403548

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403548

1 reference

Dimensions Publication ID

9 December 2017

1039462927

0 references

1 reference